Zac Renata Indelicato, da Costa Adilson
Drs. Zac and Da Costa are with the Instituto de Assistência Médica ao Servidor Público Estadual de São Paulo/São Paulo's Welfare Institute in São Paulo, Brazil.
J Clin Aesthet Dermatol. 2021 May;14(5):26-30. Epub 2021 May 1.
Androgenetic alopecia (AGA) is a common, genetically predisposed condition that begins after puberty and whose frequency increases with age; although biologically benign, AGA can impact patients both psychologically and socially, contributing to an impairment on their quality of life. We sought to evaluate the psychological, social, and quality of life impairments inherent in women with AGA using 5% minoxidil daily for at least six months. Thirty-one women with diffuse central hair thinning and shaft miniaturization who were using 5% minoxidil daily for at least six months responded to a clinical questionnaire and underwent trichoscopy. 83.9 percent (n=26) of the participants reported they were satisfied with the 5% minoxidil treatment and its convenience. Hair loss influenced social life in 54.8 percent (n=17) of the respondents and choice of hair cut/hairstyle in 87.1 percent (n=27) of respondents. For 51.6 percent (n=16) hair loss was slightly increased, although it did not increase after beginning treatment. A frontoparietal pattern (74.2%, n=23), very low capillary density (61.3%, n=19), trichodynia (32.3%, n=10), and negative traction test (100%, n=31) were also observed. Miniaturization occurred in 100 percent (n=31) of patients, frontal/occipital hair thickness was reduced in 83.9 percent (n=26), and more than 10 percent of velus hair in the frontal area was observed in 83.9 percent (n=26) of patients. The number of hair shafts per follicular unit was reduced in 67.7 percent (n=21), and a higher frontal to occipital ratio of follicular units with one hair shaft was seen in 74.2 percent (n=23) of patients. Empty follicles, large numbers of peripillar brownish halo, scalp pigmentation, mild Ludwig's baldness degree, and quality of life scores of 4±3.5 points were observed. Our results indicate that patient satisfaction and quality of life of women with AGA on 5% topical minoxidil are high, although hair loss influences daily habits and social life.
雄激素性脱发(AGA)是一种常见的、具有遗传易感性的疾病,始于青春期后,其发病率随年龄增长而增加;尽管在生物学上是良性的,但AGA会在心理和社会层面影响患者,导致其生活质量受损。我们试图评估每天使用5%米诺地尔至少六个月的AGA女性患者所固有的心理、社会和生活质量损害情况。31名每天使用5%米诺地尔至少六个月、有弥漫性中央头发稀疏和发干变细的女性患者对一份临床问卷做出了回应,并接受了毛发镜检查。83.9%(n = 26)的参与者报告称,她们对5%米诺地尔治疗及其便利性感到满意。54.8%(n = 17)的受访者表示脱发影响了社交生活,87.1%(n = 27)的受访者表示脱发影响了发型选择。51.6%(n = 16)的患者脱发略有增加,不过在开始治疗后并未加重。还观察到额顶模式(74.2%,n = 23)、极低的毛细血管密度(61.3%,n = 19)、毛发疼痛(32.3%,n = 10)以及阴性牵拉试验(100%,n = 31)。100%(n = 31)的患者出现了毛囊微型化,83.9%(n = 26)的患者额部/枕部头发厚度降低,83.9%(n = 26)的患者额部区域超过10%的毳毛被观察到。67.7%(n = 21)的患者每个毛囊单位的毛干数量减少,74.2%(n = 23)的患者观察到单根毛干毛囊单位的额部与枕部比例更高。观察到空毛囊、大量的毛囊周褐色晕、头皮色素沉着、轻度路德维希秃发程度以及生活质量评分为4±3.5分。我们的结果表明,尽管脱发会影响日常习惯和社交生活,但每天外用5%米诺地尔的AGA女性患者的满意度和生活质量较高。